CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $82,244
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$82,244. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-09-16 | St Peter Steven Director | Option exercise · Employee Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-09-16 | St Peter Steven Director | Option exercise · Employee Stock Option (right to buy) | −10,004 | 0 | ||
| 2016-09-16 | St Peter Steven Director | Option exercise · Employee Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-09-16 | GILL JOHN President and CEO | Option exercise | +10,000 | $2.59 | $26K | 702,244 |
| 2016-09-16 | GILL JOHN President and CEO | Option exercise | +20,000 | $2.47 | $49K | 722,244 |
| 2016-09-16 | GILL JOHN President and CEO | Option exercise · Employee Stock Option (right to buy) | −10,000 | 0 | ||
| 2016-09-16 | GILL JOHN President and CEO | Option exercise · Employee Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-09-15 | Runge Jeffrey W. Director | Option exercise | +20,000 | $1.35 | $27K | 57,700 |
| 2016-09-15 | Runge Jeffrey W. Director | Option exercise | +20,000 | $1.60 | $32K | 77,700 |
| 2016-09-15 | Runge Jeffrey W. Director | Option exercise | +20,000 | $1.45 | $29K | 97,700 |
| 2016-09-15 | Runge Jeffrey W. Director | Option exercise | +20,000 | $1.64 | $33K | 117,700 |
| 2016-09-15 | Runge Jeffrey W. Director | Option exercise | +20,000 | $1.51 | $30K | 137,700 |
| 2016-09-15 | Runge Jeffrey W. Director | Option exercise | +20,000 | $1.69 | $34K | 157,700 |
| 2016-09-15 | Runge Jeffrey W. Director | Option exercise · Employee Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-09-15 | Runge Jeffrey W. Director | Option exercise · Employee Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-09-15 | Runge Jeffrey W. Director | Option exercise · Employee Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-09-15 | Runge Jeffrey W. Director | Option exercise · Employee Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-09-15 | Runge Jeffrey W. Director | Option exercise · Employee Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-09-15 | Runge Jeffrey W. Director | Option exercise · Employee Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-09-15 | GILL JOHN President and CEO | Option exercise | +20,000 | $1.60 | $32K | 632,244 |
Page 38 of 43 · 845 trades